Abstract:Macrophage is the key innate immune effector in first-line defense against the pathogens, and can be polarized into different phenotypes to regulate a variety of immunological functions. However, the plasticity of macrophage is extraordinarily recruited, activated, and polarized under pathological conditions, playing paramount roles in occurrence, development, and prognosis of various chronic diseases, such as rheumatoid arthritis (RA), atherosclerosis (AS), and cancer. To this end, macrophage has become an important therapeutic target for etiological treatment of these diseases. Meanwhile, with the development of nanotechnology, various nano-drug delivery systems have been explored to target macrophages for disease modulation, displaying unique advantages to address both pharmaceutic and biopharmaceutic limitations of various drugs. This review aims to summarize the recent progress of macrophage-targeted nanomedicine for chronic diseases immunotherapy. First, the origin, polarization and biological functions of macrophages have been introduced, in which macrophages can differentiate into different phenotypes in response to physiological stimuli to play various immunological roles. Then, the macrophage disorder has been reviewed in related with various chronic diseases, and several representative diseases, including AS, RA, obesity, and cancer, have been discussed in detail to elucidate the pathological contributions of macrophages for disease progress. Next, strategies to regulate macrophages for diseases immunotherapy, such as macrophages depletion, macrophage reprograming, inhibition of macrophage recruitment, are summarized, and particular attention has been paid on bio-functional nanomaterials to engineer macrophages via different mechanisms. Further, methods for macrophage-targeting delivery nanosystems are discussed based on both passive and active targeting approaches. Finally, the perspective is speculated for potential clinical translation, and there still has significant room for the development of novel macrophage-targeting nanomedicine for precise, effective, and biosafe therapy.

Current Development of Nano-Drug Delivery to Target Macrophages

Advances in Macrophage-Targeting Nanoparticles for the Diagnosis and Treatment of Inflammatory Bowel Disease.

Nanoparticles Targeting Macrophages As Potential Clinical Therapeutic Agents Against Cancer and Inflammation

Neutrophil‐Based Delivery Systems for Nanotherapeutics

Drug delivery to macrophages: a review of nano-therapeutics targeted approach for inflammatory disorders and cancer

Neutrophils and Macrophages as Targets for Development of Nanotherapeutics in Inflammatory Diseases

Macrophage-targeted Nanomedicine for Chronic Diseases Immunotherapy

Macrophages as Nanocarriers for Drug Delivery: Novel Therapeutics for Central Nervous System Diseases.

Active Nano-targeting of Macrophages

Role of macrophage in nanomedicine-based disease treatment

Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment

Adjusting The Balance Between Effective Loading And Vector Migration Of Macrophage Vehicles To Deliver Nanoparticles

An Overview on Macrophage Targeting: A Promising Approach

Macrophage-Biomimetic Nanoplatform-Based Therapy for Inflammation-Associated Diseases.

Macrophage membrane biomimetic drug delivery system: for inflammation targeted therapy

Nanocarriers for effective delivery: modulation of innate immunity for the management of infections and the associated complications

Use of macrophage as a Trojan horse for cancer nanotheranostics

Tumor-associated macrophages in nanomaterial-based anti-tumor therapy: as target spots or delivery platforms

Recent progress of macrophage vesicle-based drug delivery systems

Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy.

Nanoparticles targeting tumor-associated macrophages: A novel anti-tumor therapy